During the past decade, Mercy Health Mercy Campus conducted 145 clinical trials. In the 10-year time frame, 145 clinical trials started and 103 clinical trials were completed, i.e. on average, 71% percent of trials that started reached the finish line to date. In the past 5 years, 59 clinical trials started and 59 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Health Mercy Campus" #1 sponsor was "National Cancer Institute (NCI)" with 121 trials, followed by "SWOG Cancer Research Network" with 35 trials sponsored, "Alliance for Clinical Trials in Oncology" with 24 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 20 trials sponsored and "NRG Oncology" with 20 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Health Mercy Campus" #1 collaborator was "National Cancer Institute (NCI)" with 119 trials as a collaborator, "NRG Oncology" with 23 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator and "Cancer and Leukemia Group B" with 5 trials as a collaborator. Other collaborators include 37 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Health Mercy Campus" are "Recurrent Breast Carcinoma" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Invasive Breast Carcinoma" (8 trials), "Stage IV Breast Cancer AJCC v6 and v7" (8 trials) and "Breast Cancer" (7 trials). Many other conditions were trialed in "Mercy Health Mercy Campus" in a lesser frequency.

Most popular intervention types in "Mercy Health Mercy Campus" are "Drug" (195 trials), "Other" (155 trials), "Biological" (93 trials), "Procedure" (60 trials) and "Radiation" (38 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (84 trials), "Quality-of-Life Assessment" (65 trials), "Questionnaire Administration" (45 trials), "Paclitaxel" (31 trials) and "Biospecimen Collection" (28 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Health Mercy Campus" are 186 trials for "All" genders, 51 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Mercy Health Mercy Campus". undefined are not yet recruiting, 61 are recruiting, 104 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 61 completed trials in Mercy Health Mercy Campus, 5 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Health Mercy Campus, 7 "Phase 1" clinical trials were conducted, 117 "Phase 2" clinical trials and 122 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".